Amyotrophic Lateral Sclerosis

Neurology and Clinical Neuroscience: Text with CD-ROM

Volumn , Issue , 2006, Pages 859-878

  Boylan, Kevin B ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450151757     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03354-1.50070-5     Document Type: Chapter

References (216)

1. Miller RG, Bradley WG, Gelinas D, et al. Amyotrophic Lateral Sclerosis. Continuum. American Academy of Neurology August 2002, Lippincott Williams & Wilkins, Hagerstown, MD, 8:(4).
2. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299. accessed March 23, 2006. http://www.wfnals.org.
3. Cleveland DW, Rothstein JD From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Natl Rev Neurosci 2001, 2:806-819.
4. Forshew DA, Bromberg MB A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:258-263.
5. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999, 52:1311-1323.
6. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
7. Cleveland DW, Rothstein JD From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Natl Rev Neurosci 2001, 2:806-819.
8. Goldblatt D Motor neuron disease: historical introduction. Motor Neuron Diseases. Research on Amyotrophic Lateral Sclerosis and Related Disorders: Contemporary Neurology Symposia 1968, vol 2:3-11. Grune & Stratton, New York. F.H. Norris, L.T. Kurland (Eds.).
9. Strong M, Rosenfeld J Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:136-143.
10. Borasio GD, Miller RG Clinical characteristics and management of ALS. Semin Neurol 2001, 21:155-166.
11. Carter GT, Krivickas LS, Weydt P, et al. Drug therapy for amyotrophic lateral sclerosis: where are we now?. IDrugs 2003, 6:147-153.
12. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999, 52:1311-1323.
13. Rowland LP, Shneider NA Amyotrophic lateral sclerosis. N Engl J Med 2001, 344:1688-1700.
14. Desai J, Swash M Essentials of diagnosis. Motor Neuron Disease 2002, 1-20. WB Saunders, Philadelphia. R.W. Kuncl (Ed.).
15. Younger DS, Chou S, Hays AP, et al. Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol 1988, 45:1304-1307.
16. Krvickas L Pulmonary function and respiratory failure. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 382-404. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
17. Ince PG, Lowe J, Shaw PJ Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998, 24:104-117.
18. Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993, 118:48-55.
19. Brooks BR El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Sub-committee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" workshop contributors. J Neurol Sci 1994, 124(Suppl):96-107.
20. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
21. Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000, 57:1171-1176.
22. Ince PG Neuropathology. Amyotrophic Lateral Sclerosis 2000, 83-112. Martin Dunitz, London. R.H. Brown, V. Meininger, M. Swash (Eds.).
23. Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985, 232:295-300.
24. Jokelainen M Amyotrophic lateral sclerosis in Finland. II: clinical characteristics. Acta Neurol Scand 1977, 56:194-204.
25. Brooks BR Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases: Advances in Neurology 1991, vol 56:521-546. Raven Press, New York. L.P. Rowland (Ed.).
26. Kuncl RW, Cornblath DR, Griffin JW Assessment of thoracic paraspinal muscles in the diagnosis of ALS. Muscle Nerve 1988, 11:484-492.
27. Conradi S, Ronnevi LO, Norris FH Motor neuron disease and toxic metals. Adv Neurol 1982, 36:201-231.
28. Roth G Fasciculations and their F-response. Localisation of their axonal origin. J Neurol Sci 1984, 63:299-306.
29. Wettstein A The origin of fasciculations in motoneuron disease. Ann Neurol 1979, 5:295-300.
30. Blexrud MD, Windebank AJ, Daube JR Long-term follow-up of 121 patients with benign fasciculations. Ann Neurol 1993, 34:622-625.
31. Robbins J Swallowing in ALS and motor neuron disorders. Neurol Clin 1987, 5:213-229.
32. Parvizi J, Anderson SW, Martin CO, et al. Pathological laughter and crying: a link to the cerebellum. Brain 2001, 124:1708-1719.
33. Gallagher JP Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989, 80:114-117.
34. Fromm GB, Wisdom PJ, Block AJ Amyotrophic lateral sclerosis presenting with respiratory failure. Diaphragmatic paralysis and dependence on mechanical ventilation in two patients. Chest 1977, 71:612-614.
35. Hill R, Martin J, Hakim A Acute respiratory failure in motor neuron disease. Arch Neurol 1983, 40:30-32.
36. Nightingale S, Bates D, Bateman DE, et al. Enigmatic dyspnoea: an unusual presentation of motor-neurone disease. Lancet 1982, 1:933-935.
37. Fallat RJ, Jewitt B, Bass M, et al. Spirometry in amyotrophic lateral sclerosis. Arch Neurol 1979, 36:74-80.
38. Kreitzer SM, Saunders NA, Tyler R, et al. Respiratory muscle function in amyotrophic lateral sclerosis. Chest 1978, 73:266-267.
39. Gibson GJ Diaphragmatic paresis: pathophysiology, clinical features, and investigation. Thorax 1989, 44:960-970.
40. Grinman S, Whitelaw WA Pattern of breathing in a case of generalized respiratory muscle weakness. Chest 1983, 84:770-772.
41. Goldstein RS Hypoventilation: neuromuscular and chest wall disorders. Clin Chest Med 1992, 13:507-521.
42. Caselli RJ, Windebank AJ, Petersen RC, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993, 33:200-207.
43. van den Berg-Vos RM, Visser J, Franssen H, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 2003, 126:1036-1047.
44. Mortara P, Chio A, Rosso MG, et al. Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. J Neurol Sci 1984, 66:165-173.
45. Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003, 60:1252-1258.
46. Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997, 146:139-143.
47. Pearn J Autosomal dominant spinal muscular atrophy: a clinical and genetic study. J Neurol Sci 1978, 38:263-275.
48. Rudnik-Schoneborn S, Rohrig D, Morgan G, et al. Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: clinical picture, influence of gender, and genetic implications. Am J Med Genet 1994, 51:70-76.
49. Somerville MJ, Hunter AG, Aubry HL, et al. Clinical application of the molecular diagnosis of spinal muscular atrophy: deletions of neuronal apoptosis inhibitor protein and survival motor neuron genes. Am J Med Genet 1997, 69:159-165.
50. Harding AE, Thomas PK Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980, 17:329-336.
51. Kennedy WR, Alter M, Sung JH Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968, 18:671-680.
52. Harding AE, Thomas PK, Baraitser M, et al. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 1982, 45:1012-1019.
53. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
54. Olney RK, Aminoff MJ, So YT Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy. Neurology 1991, 41:823-828.
55. Katz JS, Wolfe GI, Andersson PB, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 1999, 53:1071-1076.
56. Hu MT, Ellis CM, Al-Chalabi A, et al. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998, 65:950-951.
57. Hirayama K, Tomonaga M, Kitano K, et al. Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. J Neurol Neurosurg Psychiatry 1987, 50:285-290.
58. Hirayama K, Tokumaru Y Cervical dural sac and spinal cord in juvenile muscular atrophy of distal upper extremity. Neurology 2000, 54:1922-1926.
59. de Visser M, Ongerboer de Visser BW, et al. Amyotrophy of the hands and pyramidal features of predominantly the legs segregating within one large family. J Neurol Sci 1988, 88:241-246.
60. Rowland LP, Schneck SA Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Dis 1963, 16:777-795.
61. Gordon PH, Rowland LP, Younger DS, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997, 48:1671-1678.
62. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991, 29:78-86.
63. Rowland LP, Sherman WH, Latov N, et al. Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests. Neurology 1992, 42:1101-1102.
64. Jubelt B, Cashman NR Neurological manifestations of the post-polio syndrome. Crit Rev Neurobiol 1987, 3:199-220.
65. Trojan DA, Cashman NR Post-poliomyelitis syndrome. Muscle Nerve 2005, 31:6-19.
66. Dalakas MC, Elder G, Hallett M, et al. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 1986, 314:959-963.
67. Johnson WG The clinical spectrum of hexosaminidase deficiency diseases. Neurology 1981, 31:1453-1456.
68. Mitsumoto H, Sliman RJ, Schafer IA, et al. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol 1985, 17:378-385.
69. Cashman NR, Antel JP, Hancock LW, et al. N-acetyl-β-hexosaminidase β locus defect and juvenile motor neuron disease: a case study. Ann Neurol 1986, 19:568-572.
70. Nagale SV, Bosch EP Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment. Semin Neurol 2003, 23:325-334.
71. Nobile-Orazio E, Meucci N, Barbieri S, et al. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993, 43:537-544.
72. Bouche P, Moulonguet A, Younes-Chennoufi AB, et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995, 59:38-44.
73. Lange DJ, Trojaborg W, Latov N, et al. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?. Neurology 1992, 42:497-505.
74. Pestronk A, Chaudhry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990, 27:316-326.
75. Kelly JJ Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle Nerve 1985, 8:138-150.
76. Ropper AH, Gorson KC Neuropathies associated with paraproteinemia. N Engl J Med 1998, 338:1601-1607.
77. Rowland LP, Defendini R, Sherman W, et al. Macroglobulinemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol 1982, 11:532-536.
78. Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990, 40:595-599.
79. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982, 32:958-964.
80. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993, 33:333-342.
81. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989, 46:878-884.
82. Drachman DB Myasthenia gravis. N Engl J Med 1994, 330:1797-1810.
83. Keesey JC Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004, 29:484-505.
84. McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004, 55:580-584.
85. Mareska M, Gutmann L Lambert-Eaton myasthenic syndrome. Semin Neurol 2004, 24:149-153.
86. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other para-neoplastic syndromes. N Engl J Med 1995, 332:1467-1474.
87. Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis. Observations in 40 patients. Brain 1989, 112(Pt 3):727-747.
88. Dalakas MC Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991, 325:1487-1498.
89. Mitsumoto H, Chad D, Pioro E The differential diagnosis of ALS. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 87-121. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
90. Le Forestier N, Maisonobe T, Spelle L, et al. Primary lateral sclerosis: further clarification. J Neurol Sci 2001, 185:95-100.
91. Pringle CE, Hudson AJ, Munoz DG, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992, 115(Pt 2):495-520.
92. Gastaut JL, Bartolomei F Mills' syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis?. J Neurol Neurosurg Psychiatry 1994, 57:1280-1281.
93. Hudson AJ, Kiernan JA, Munoz DG, et al. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis. Brain Res Bull 1993, 30:359-364.
94. Kojan S, Goodwin W, Bryan WW, et al. Clinical and laboratory features of primary lateral sclerosis. J Child Neurol 2000, 15:200.
95. Brownell B, Oppenheimer DR, Hughes JT The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970, 33:338-357.
96. Fortini D, Cricchi F, Di Fabio R, et al. Current insights into familial spastic paraparesis: new advances in an old disease. Funct Neurol 2003, 18:43-49.
97. Fink JK Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol 2001, 21:199-207.
98. Fink JK The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 2003, 60:1045-1049.
99. Bouslam N, Benomar A, Azzedine H, et al. Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Ann Neurol 2005, 57:567-571.
100. Rowland LP Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998, 160(Suppl 1):S6-S24.
101. Yamada M, Furukawa Y, Hirohata M Amyotrophic lateral sclerosis: frequent complications by cervical spondylosis. J Orthop Sci 2003, 8:878-881.
102. Noseworthy JH, Heffernan LP Motor radiculopathy-an unusual presentation of multiple sclerosis. Can J Neurol Sci 1980, 7:207-209.
103. Fisher M, Long RR, Drachman DA Hand muscle atrophy in multiple sclerosis. Arch Neurol 1983, 40:811-815.
104. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 2000, 6:544-548.
105. MacGowan DJ, Scelsa SN, Waldron M An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2001, 57:1094-1097.
106. von Giesen HJ, Kaiser R, Koller H, et al. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2002, 59:474. author reply,.
107. Neurology 2002, 59:474-475. [Erratum in Neurology 2002; 59:2009].
108. Mariani C, Cislaghi MG, Barbieri S, et al. The natural history and results of surgery in 50 cases of syringomyelia. J Neurol 1991, 238:433-438.
109. Griffin JW, Goren E, Schaumburg H, et al. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology 1977, 27:1107-1113.
110. Mitsumoto H, Chad D, Pioro E History, terminology, and classification of ALS. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 3-17. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
111. Sawaya RA Foramen magnum meningioma presenting as amyotrophic lateral sclerosis. Neurosurg Rev 1998, 21:277-280.
112. Fan X, Rouleau GA Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy. Can J Neurol Sci 2003, 30:8-14.
113. Noseworthy JH, Rae-Grant AD, Brown WF An unusual subacute progressive motor neuronopathy with myasthenia-like features. Can J Neurol Sci 1988, 15:304-309.
114. Hayashi H, Kato S, Kawada A Amyotrophic lateral sclerosis patients living beyond respiratory failure. J Neurol Sci 1991, 105:73-78.
115. Kuncl RW Errors in diagnosis. Motor Neuron Disease 2002, 21-38. WB Saunders, London. R.W. Kuncl (Ed.).
116. Lomen-Hoerth C Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 2004, 17:337-341.
117. Kondo K, Hemmi I Clinical statistics in 515 fatal cases of motor neuron disease. Neuroepidemiology 1984, 3:129-148.
118. Hosler BA, Siddique T, Sapp PC, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000, 284:1664-1669.
119. Qureshi AI, Wilmot G, Dihenia B, et al. Motor neuron disease with parkinsonism. Arch Neurol 1996, 53:987-991.
120. Liang TW, Forman MS, Duda JE, et al. Multiple pathologies in a patient with a progressive neurodegenerative syndrome. J Neurol Neurosurg Psychiatry 2005, 76:252-255.
121. Rodgers-Johnson P, Garruto RM, Yanagihara R, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology 1986, 36:7-13.
122. Armon C Epidemiology of amyotrophic lateral sclerosis/motor neuron disease. Motor Neuron Disorders: Blue Books of Practical Neurology 2003, 167-205. Butterworth-Heinemann, Philadelphia. P.J. Shaw, M.J. Strong (Eds.).
123. Gilbert JJ, Kish SJ, Chang LJ, et al. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Ann Neurol 1988, 24:688-691.
124. Hudson AJ Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981, 104:217-247.
125. Schmitt HP, Emser W, Heimes C Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 1984, 16:642-648.
126. Waring SC, Esteban-Santillan C, Reed DM, et al. Incidence of amyotrophic lateral sclerosis and of the parkinsonismdementia complex of Guam, 1950-1989. Neuroepidemiology 2004, 23:192-200.
127. Kunst CB Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet 2004, 75:933-947.
128. Furtado S, Payami H, Lockhart PJ, et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 2004, 19:622-629.
129. Strong MJ, Lomen-Hoerth C, Caselli RJ, et al. Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol 2003, 54(Suppl 5):S20-S23.
130. Siddique T, Lalani I Genetic aspects of amyotrophic lateral sclerosis. Adv Neurol 2002, 88:21-32.
131. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
132. Andersen PM, Sims KB, Xin WW, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:62-73.
133. Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004, 74:1128-1135.
134. De Jonghe P, Auer-Grumbach M, Irobi J, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?. Brain 2002, 125:1320-1325.
135. Hand CK, Khoris J, Salachas F, et al. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet 2002, 70:251-256.
136. Chance PF, Rabin BA, Ryan SG, et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998, 62:633-640.
137. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001, 29:166-173.
138. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001, 29:160-165.
139. Hentati A, Ouahchi K, Pericak-Vance MA, et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 1998, 2:55-60.
140. Cleveland JL A new piece of the ALS puzzle. Nat Genet 2003, 34:357-358.
141. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003, 34:383-394.
142. Veldink JH, van den Berg LH, Cobben JM, et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 2001, 56:749-752.
143. Corcia P, Mayeux-Portas V, Khoris J, et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol 2002, 51:243-246.
144. Veldink JH, Kalmijn S, Groeneveld GJ, et al. Physical activity and the association with sporadic ALS. Neurology 2005, 64:241-245.
145. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology 2005, 64:32-37.
146. Daube JR Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 2000, 23:1488-1502.
147. Lambert EH, Mulder DW Electromyography in amyotrophic lateral sclerosis. Motor Neuron Diseases; Research on Amyotrophic Lateral Sclerosis and Related Disorders: Contemporary Neurology Symposia 1968, vol 2:135-153. Grune & Stratton, New York. F.H. Norris, L.T. Kurland (Eds.).
148. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 1994, 17:198-205.
149. Olney RK, Lewis RA, Putnam TD, et al. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003, 27:117-121.
150. Cornblath DR, Kuncl RW, Mellits ED, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992, 15:1111-1115.
151. Henderson RD, Daube JR Decrement in surface-recorded motor unit potentials in amyotrophic lateral sclerosis. Neurology 2004, 63:1670-1674.
152. Cornblath DR, Kuncl RW, Rechthand E, et al. The value of rectus abdominal muscle electromyography [Letter]. Muscle Nerve 1987, 10:376.
153. Gooch CL, Shefner JM ALS surrogate markers. MUNE. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5(Suppl 1):104-107.
154. Osei-Lah AD, Mills KR Optimising the detection of upper motor neuron function dysfunction in amyotrophic lateral sclerosis-a transcranial magnetic stimulation study. J Neurol 2004, 251:1364-1369.
155. Kaufmann P, Pullman SL, Shungu DC, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004, 62:1753-1757.
156. Theys PA, Peeters E, Robberecht W Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J Neurol 1999, 246:438-442.
157. Mitsumoto H, Chad D, Pioro E Electrodiagnosis. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 78-79. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
158. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005, 64:38-43.
159. Kaufmann P, Mitsumoto H Amyotrophic lateral sclerosis: objective upper motor neuron markers. Curr Neurol Neurosci Rep 2002, 2:55-60.
160. Kalra S, Arnold D Neuroimaging in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:243-248.
161. da Rocha AJ, Oliveira AS, Fonseca RB, et al. Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spinecho magnetization transfer contrast sequence. AJNR Am J Neuroradiol 2004, 25:1509-1515.
162. Mitsumoto H, Chad D, Pioro E Diagnostic evaluation of ALS. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 125-128. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
163. Cudkowicz M, Qureshi M, Shefner J Measures and markers in amyotrophic lateral sclerosis. NeuroRx 2004, 1:273-283.
164. Shefner JM Multi-drug therapy in amyotrophic lateral sclerosis: combinations of multiple, untested drugs should not be used at this time. Muscle Nerve 2004, 30:676-678.
165. Miller RG, Mitchell JD, Lyon M, et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:191-206.
166. Meucci N, Nobile-Orazio E, Scarlato G Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J Neurol 1996, 243:117-120.
167. Miller R Pharmacology and clinical trials. Continuum: Amyotrophic Lateral Sclerosis 2002, 8:56-81.
168. Orrell RW, Lane JM, Ross MA Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2004, (4). CD002829.
169. Miller ER, Pastor-Barriuso R, Dalal D, et al. Metaanalysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
170. Pioro EP Antioxidant therapy in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 4):5-12. discussion,.
171. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(Suppl 4):13-15.
172. Shefner JM, Cudkowicz ME, Schoenfeld D, et al. A clinical trial of creatine in ALS. Neurology 2004, 63:1656-1661.
173. Carelli V, Liguori R, Cordivari C, et al. Ceftriaxone is ineffective in ALS. Ital J Neurol Sci 1994, 15:66.
174. Couratier P, Vallat JM, Merle L, et al. Report of six sporadic cases of ALS patients receiving ceftriaxone. Therapie 1994, 49:146.
175. Rothstein JD, Patel S, Regan MR, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
176. Silani V, Cova L, Corbo M, et al. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004, 364:200-202.
177. Watts J Controversy in China. Lancet 2005, 365:109-110.
178. Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003, 74:1258-1261.
179. Forshew DA, Bromberg MB A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:258-263.
180. Sufit R, Miller R Symptomatic management. Continuum: Amyotrophic Lateral Sclerosis 2002, 8:82-94.
181. Marquardt G, Lorenz R Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis. J Neurol 1999, 246:619-620.
182. Bourke SC, Bullock RE, Williams TL, et al. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003, 61:171-177.
183. Gelanis DF Respiratory failure or impairment in amyotrophic lateral sclerosis. Curr Treat Options Neurol 2001, 3:133-138.
184. Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004, 29:5-27.
185. Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000, 69:121-123.
186. Winterholler MG, Erbguth FJ, Wolf S, et al. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry 2001, 70:417-418.
187. Tan EK, Lo YL, Seah A, et al. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci 2001, 190:95-97.
188. Andersen PM, Gronberg H, Franzen L, et al. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J Neurol Sci 2001, 191:111-114.
189. Harriman M, Morrison M, Hay J, et al. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis. J Otolaryngol 2001, 30:242-245.
190. Mitsumoto H, Davidson M, Moore D, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:177-185.
191. Chio A, Galletti R, Finocchiaro C, et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry 2004, 75:645-647.
192. Thornton FJ, Fotheringham T, Alexander M, et al. Amyotrophic lateral sclerosis: enteral nutrition provision-endoscopic or radiologic gastrostomy?. Radiology 2002, 224:713-717.
193. Rio A, Leigh N Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 2001, 57:1351. discussion,.
194. Neurology 2001, 57:1351-1352.
195. Mitsumoto H, Chad D, Pioro E Speech and communication management. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 405-420. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
196. Yorkston KM Treatment efficacy: dysarthria. J Speech Hear Res 1996, 39:S46-S57.
197. Schiffer RB, Herndon RM, Rudick RA Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 1985, 312:1480-1482.
198. Iannaccone S, Ferini-Strambi L Pharmacologic treatment of emotional lability. Clin Neuropharmacol 1996, 19:532-535.
199. Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004, 63:1364-1370.
200. Moretti R, Torre P, Antonello RM, et al. Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging 2004, 21:931-937.
201. Newsom-Davis IC, Lyall RA, Leigh PN, et al. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry 2001, 71:482-487.
202. Mitsumoto H, Chad D, Pioro E Symptomatic treatment. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 321-328. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
203. Bradley WG, Anderson F, Bromberg M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001, 57:500-504.
204. Borasio GD, Voltz R, Miller RG Palliative care in amyotrophic lateral sclerosis. Neurol Clin 2001, 19:829-847.
205. Mazzini L, Corra T, Zaccala M, et al. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995, 242:695-698.
206. Aboussouan LS, Khan SU, Banerjee M, et al. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001, 24:403-409.
207. Mitsumoto H, Chad D, Pioro E Course and prognosis. Amyotrophic Lateral Sclerosis: Contemporary Neurology Series 49 1998, 151-163. FA Davis, Philadelphia. H. Mitsumoto, D.A. Chad, E.P. Pioro (Eds.).
208. Magnus T, Beck M, Giess R, et al. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002, 25:709-714.
209. del Aguila MA, Longstreth WT, McGuire V, et al. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003, 60:813-819.
210. Chio A, Mora G, Leone M, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002, 59:99-103.
211. Turner M, Al-Chalabi A Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002, 59:2012-2013. author reply, Neurology 2002; 59:2013.
212. Daube JR Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases. Neurol Clin 1985, 3:473-493.
213. Bernstein LP, Antel JP Motor neuron disease: decremental responses to repetitive nerve stimulation. Neurology 1981, 31:204-207.
214. Wang FC, De Pasqua V, Gerard P, et al. Prognostic value of decremental responses to repetitive nerve stimulation in ALS patients. Neurology 2001, 57:897-899.
215. Mulder DW, Howard FM Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976, 51:537-541.
216. Tucker T, Layzer RB, Miller RG, et al. Subacute, reversible motor neuron disease. Neurology 1991, 41:1541-1544.